Your browser doesn't support javascript.
loading
Global status of diabetes prevention and prospects for action: A consensus statement.
Ibrahim, Mahmoud; Tuomilehto, Jaakko; Aschner, Pablo; Beseler, Lucille; Cahn, Avivit; Eckel, Robert H; Fischl, Amy Hess; Guthrie, George; Hill, James O; Kumwenda, Mick; Leslie, R David; Olson, Darin E; Pozzilli, Paolo; Weber, Sandra L; Umpierrez, Guillermo E.
Afiliação
  • Ibrahim M; EDC Center for Diabetes Education, McDonough, GA, USA.
  • Tuomilehto J; Dasman Diabetes Institute, Kuwait, Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland, and Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Aschner P; Javeriana University School of Medicine, San Ignacio University Hospital, Bogota, Colombia.
  • Beseler L; Family Nutrition Center of South Florida, Coconut Creek, FL, USA.
  • Cahn A; Hadassah Hebrew University Hospital, The Diabetes Unit & Endocrinology and Metabolism Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel.
  • Eckel RH; University of Colorado Denver Anschutz Medical Campus, University of Colorado Hospital, Denver, CO, USA.
  • Fischl AH; University of Chicago Kovler Diabetes Center, Chicago, IL, USA.
  • Guthrie G; Florida Hospital Graduate Medical Education, Orlando, FL, USA.
  • Hill JO; Colorado Nutrition Obesity Research Center (NORC), University of Colorado School of Medicine, Aurora, CO, USA.
  • Kumwenda M; Glan Clwyd Hospital, Rhyl, UK.
  • Leslie RD; Blizard Institute, Queen Mary, University of London, London, UK.
  • Olson DE; Division of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, Atlanta, GA, USA.
  • Pozzilli P; Unit of Endocrinology and Diabetes, University Campus Bio-Medico, Rome, Italy.
  • Weber SL; Centre of Immunobiology, Barts and the London School of Medicine, Queen Mary, University of London, London, UK.
  • Umpierrez GE; Greenville Health System, University of South Carolina School of Medicine-Greenville, Greenville, SC, USA.
Diabetes Metab Res Rev ; 34(6): e3021, 2018 09.
Article em En | MEDLINE | ID: mdl-29757486
ABSTRACT
Primary prevention of type 2 diabetes (T2D) should be achievable through the implementation of early and sustainable measures. Several randomized control studies that found success in preventing the progression to T2D in high-risk populations have identified early and intensive intervention based on an individualized prevention model as the key factor for participant benefit. The global prevalence of both overweight and obesity has now been widely recognized as the major epidemic of the 21st century. Obesity is a major risk factor for the progression from normal glucose tolerance to prediabetes and then to T2D. However, not all obese individuals will develop prediabetes or progress to diabetes. Intensive, multicomponent behavioural interventions for overweight and obese adults can lead to weight loss. Diabetes medications, including metformin, GLP-1 agonists, glitazones, and acarbose, can be considered for selected high-risk patients with prediabetes when lifestyle-based programmes are proven unsuccessful. Nutrition education is the cornerstone of a healthy lifestyle. Also, physical activity is an integral part of the prediabetes management plan and one of the main pillars in the prevention of diabetes. Mobile phones, used extensively worldwide, can facilitate communication between health professionals and the general population, and have been shown to be helpful in the prevention of T2D. Universal screening is needed. Noninvasive risk scores should be used in all countries, but they should be locally validated in all ethnic populations focusing on cultural differences around the world. Lifestyle interventions reduce the progression to prediabetes and diabetes. Nevertheless, many questions still need to be answered.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Prevenção Primária / Saúde Global / Consenso / Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Diabetes Metab Res Rev Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Prevenção Primária / Saúde Global / Consenso / Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Diabetes Metab Res Rev Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos